Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro

Area of Science:

• Stem Cell Biology
• Endothelial Cell Differentiation
• Vascular Biology

Background:

• Clinical relevance of stem cell therapies hinges on in vitro differentiated cells functionally mimicking in vivo counterparts.
• Mouse embryonic stem cells (ESC) can be differentiated into endothelial cells (EC).

Purpose of the Study:

• To compare the characteristics of ESC-derived endothelial cells (ESC-EC) with mouse aortic endothelial cells (MAEC).
• To assess the functional and phenotypic similarities and differences between ESC-EC and MAEC.

Main Methods:

• Derivation of >96% purity endothelial cells from mouse ESC.
• Comparison with primary mouse aortic endothelial cells (MAEC).
• Immunocytochemical analysis of EC markers (eNOS, Flk-1, Flt-1, VE-cadherin, PECAM-1, CD34).
• Assessment of acetylated low-density lipoprotein (LDL) uptake and von Willebrand factor expression.
• Evaluation of VE-cadherin localization at cell-cell junctions.
• Analysis of vasculogenic and angiogenic sprouting potential.

Main Results:

• Both ESC-EC and MAEC express key EC markers (eNOS, Flk-1, Flt-1, VE-cadherin, PECAM-1, CD34).
• ESC-EC show lower levels of PECAM-1, VE-cadherin, LDL uptake, and von Willebrand factor compared to MAEC.
• VE-cadherin localization at cell junctions is less organized in ESC-EC than MAEC.
• ESC-EC exhibit significantly higher CD34 expression and greater vasculogenic/angiogenic sprouting potential than MAEC.

Conclusions:

• ESC-derived EC share crucial characteristics with mature EC but retain markers of immature phenotypes.
• ESC-EC possess distinct properties, including elevated CD34 expression and enhanced sprouting capabilities, suggesting potential for regenerative applications.
• Further research is needed to fully elucidate the functional capacity and therapeutic potential of ESC-derived EC.